Shanxi Zhendong Pharmaceutical Co Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanxi Zhendong Pharmaceutical Co Ltd with three other
companies in this sector in CHINA :
Changjiang Runfa Medicine Co Ltd
sales of 5.07 billion Chinese Renmimbi [US$730.35 million]
of which 71%
Shandong Lukang Pharmaceutical
(3.73 billion Chinese Renmimbi [US$537.40 million]
of which 72%
was Human Antibiotic), and
Tianjin Chase Sun Pharmaceutical Company Limited
(5.00 billion Chinese Renmimbi [US$720.27 million]
of which 54%
During the year ended December of 2019, sales at
Shanxi Zhendong Pharmaceutical Co Ltd were 4.40 billion Chinese Renmimbi (US$633.29 million).
increase of 28.6%
versus 2018, when the company's sales were 3.42 billion Chinese Renmimbi.
Sales of Medicinal Curb Planting saw an increase
that was more than double the company's growth rate: sales were up
62.5% in 2019, from
152.25 million Chinese Renmimbi to 247.39 million Chinese Renmimbi.
Not all segments of Shanxi Zhendong Pharmaceutical Co Ltd experienced an increase in sales in 2019:
sales of Technology Service fell 23.4% to 54.03 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).